GlassScriptPhysician profile
Matthew Jergenson
NPI 1235691072
$1,124.43
in general payments reported to CMS, 2019-2025
7 companies · $597 in 2025
The $597 reported for 2025 was more than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $126 · 2023: $114 · 2024: $288 · 2025: $597.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $725 · Education: $273.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $725.25 |
| Education | $273.16 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $382.72 | 2023-2025 | Ensite, Cardiomems |
| Impulse Dynamics (USA) INC. | $202.00 | 2023-2025 | Optimizer, Optimizer |
| Acist Medical Systems, INC. | $187.10 | 2024 | |
| Amgen INC. | $145.57 | 2024-2025 | |
| Sanofi-Aventis U.S. LLC | $112.55 | 2022 | |
| Abiomed | $81.02 | 2023 | Impella |
| Biotronik INC. | $13.47 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Matthew Jergenson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.